Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Hemodynamic monitoring systems directly measure blood pressure from inside the veins, heart and arteries. They also measure blood flow and oxygen in the blood. In addition, these systems have interfaces to help document diagnostic catheterizations, coronary, peripheral and electrophysiology (EP) procedures. This may include charting, device usage, specific site identification, fractional flow reserve (FFR), sheath exchanges, and automatic timers to record balloon inflation time and pressures applied. The data gathered by the system helps speed workflow by automatically generating reports and auto-fills report fields and billing information. Hemodynamic monitoring combined with oxygen transport assessment has been used to differentiate the relative magnitude of pulmonary and cardiovascular dysfunction that contribute to hypoxemia. All patients admitted to the ICU require standard basic hemodynamic monitoring such as, ECG, heart rate, blood pressure, central venous pressure, temperature, peripheral venous oxygen saturation, blood gas analysis.
The global hemodynamic monitoring systems market is observing significant growth owing to rising prevalence of cardiovascular diseases and diabetes. The market is further boosted by rising geriatric population and growing number of surgeries. In addition, increasing per capita income is enabling people to take up advanced procedures, thus driving the growth of this market. Active role of healthcare agencies and government in creating awareness about various diseases is also expected to facilitate the growth of hemodynamic monitoring systems, thereby supporting market development. However, the market is hindered by risks associated with invasive hemodynamic monitoring.
The report analyses the global hemodynamic monitoring systems market based on product, type, end user and geography.
Based on product, the market is categorized into monitors and disposables. The disposables segment is further bifurcated into airflow sensors, circuits, and probes.
The hemodynamic monitoring systems market offers types including invasive, minimally invasive and noninvasive systems. LiDCO LXi bu ICU medical is a Noninvasive Hemodynamic Monitoring System. The systemcontinuously monitor blood pressure, cardiac output, stroke volume, and other critical hemodynamic parameters. It has dual finger oscillometric cuff which provides continuous, beat-to-beat blood pressure monitoring and real-time hemodynamic parameters.
Furthermore, various end users of this market are categorized into hospitals, ambulatory surgical centers, home care settings and clinics. The hospitals comprise surgical units based in hospitals or attached to hospitals that are equipped with instruments and accessories, to perform procedures for diagnostic or treatment of various disorders.
By geography, the global hemodynamic monitoring systems market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and rest of the world. In 2018, North America held the largest revenue share mainly due to factors such as government support for quality healthcare, high purchasing power parity, availability of reimbursement, and increasing prevalence of cancers in U.S. and Canada. For instance, in February 2018, Getinge received FDA 510(k) clearance for PulsioFlex Monitoring System and PiCCO Module, which is used for hemodynamic management of critically ill patients. According to the American Heart Association, 2017, around 209,000 patients in the U.S. were admitted in the ICU suffering from cardiac arrest and their heart activity was consistently monitored.
Furthermore, Asia Pacific is expected to witness lucrative growth over the forecast period owing to supportive government initiatives and improving healthcare infrastructure. Additionally, economic developments in countries, such as India and China, are expected to help spur the market growth. Huge population base with low per capita income in the region led to high demand for affordable treatment options.
The leading hemodynamic monitoring systems market players are Caretaker Medical, Cheetah Medical, Cnsystems Medizintechnik GmbH, Deltex Medical Group PLC, Edwards Lifesciences Corporation, ICU Medical, Lidco Group, NI Medical, Osypka Medical GmbH, Pulsion Medical Systems Se (Maquet Getinge Group) and Uscom. For instance, in March 2017, Teleflex announced 510(k) clearance by the Food and Drug Administration and US commercial launch of the TrapLiner Catheter. The TrapLiner Catheter was developed by Vascular Solutions, Inc., which was acquired by Teleflex on February 17, 2017.
The global hemodynamic monitoring systems market is segmented based on product, type, end user and geography. Based on product, the market is categorized into monitors and disposables. The disposables segment is further bifurcated into airflow sensors, circuits, and probes.
The hemodynamic monitoring systems market offers types including invasive, minimally invasive and noninvasive systems. LiDCO LXi bu ICU medical is a Noninvasive Hemodynamic Monitoring System.
Furthermore, various end users of this market are categorized into hospitals, ambulatory surgical centers, home care settings and clinics. The hospitals comprise surgical units based in hospitals or attached to hospitals that are equipped with instruments and accessories, to perform procedures for diagnostic or treatment of various disorders.
By geography, the global hemodynamic monitoring systems market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and rest of the world. In 2018, North America held the largest revenue share mainly due to factors such as government support for quality healthcare, high purchasing power parity, availability of reimbursement, and increasing prevalence of cancers in U.S. and Canada.
Why to buy this report:
